We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKingfisher Regulatory News (KGF)

Share Price Information for Kingfisher (KGF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 247.00
Bid: 246.90
Ask: 247.00
Change: -0.10 (-0.04%)
Spread: 0.10 (0.041%)
Open: 248.50
High: 249.80
Low: 245.80
Prev. Close: 247.10
KGF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Repurchase Programme - Third Tranche

24 Nov 2022 07:30

RNS Number : 4202H
Kingfisher PLC
24 November 2022
 

 

 

KINGFISHER PLC

Share repurchase programme - Third Tranche

 

24 November 2022: Kingfisher plc (the "Company" or "Kingfisher") announces that it has instructed BNP Paribas Exane ("BNP Paribas Exane") in relation to an irrevocable non-discretionary programme to purchase its shares for cancellation, during the period which commences today and ends no later than 28 April 2023 (the "Tranche"). BNP Paribas Exane will act as principal for the simultaneous on-sale of such shares to the Company and will make its trading decisions concerning the timing of the purchases of the Company's ordinary shares independently of the Company.

 

The maximum amount allocated to the Tranche (excluding expenses) will be no greater than £50 million (Note 1). The purpose of the Tranche is to reduce the share capital of the Company. As such, the Company will cancel any ordinary shares purchased. This is the third tranche of an overall commitment by the Company to purchase £300 million of its shares for cancellation, as announced on 23 May 2022 (the "Programme").

 

Any acquisitions under the Programme will be carried out within certain pre-set parameters, and in accordance with the Company's general authority to repurchase shares, the EU Market Abuse Regulation (596/2014) as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 and Chapter 12 of the Listing Rules. The Company confirms that it currently has no unpublished price sensitive information.

 

For the avoidance of doubt, no repurchases will be made in respect of the Company's American Depositary Receipts.

 

BNP Paribas Exane (or any affiliate) may undertake transactions in Ordinary Shares (which may include sales, derivatives, and other hedging activities, in addition to purchases) in order to manage its risk positions arising directly or indirectly from the Programme. Disclosure of any such transactions will not be made by BNP Paribas Exane (or any affiliate) as a result of or as part of the Programme, but BNP Paribas Exane (or any affiliate) will make any disclosures they are legally required to make in relation to such transactions.

 

Note 1. The maximum number of shares that the Company may purchase would be 172,923,195 ordinary shares of 15 5/7 pence each, in line with the authority granted to Kingfisher by shareholders at the Company's Annual General Meeting on 22 June 2022 and taking in to account the 31,306,331 shares purchased and cancelled during the previous tranche completed on 29 September 2022.

 

 

Contacts

Tel:

Email:

Company Secretary

+44 (0) 77 6880 6248

secretariat@kingfisher.com

Investor Relations

+44 (0) 20 7644 1082

investorenquiries@kingfisher.com

Treasury

+44 (0) 20 7644 1170

treasury@kingfisher.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBCBDBSBDDGDX
Date   Source Headline
26th Apr 20245:05 pmRNSDirector/PDMR Shareholding
26th Apr 20245:00 pmRNSDirector/PDMR Shareholding
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20244:00 pmRNSDirector/PDMR Shareholding
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 202411:00 amRNSDirector/PDMR Shareholding
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 202411:00 amRNSDirector/PDMR Shareholding
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 202412:03 pmRNSAnnual Financial Report & Notice of AGM
15th Apr 20247:00 amRNSDirectorate Changes
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20243:30 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:30 amRNSShare Repurchase Programme - Second Tranche
25th Mar 20247:00 amRNSFinal Results (Part 2 of 2)
25th Mar 20247:00 amRNSFinal Results (Part 1 of 2)
7th Mar 20249:00 amRNSDirector Declaration
1st Mar 202411:00 amRNSTotal Voting Rights
22nd Feb 20244:15 pmRNSHolding(s) in Company
9th Feb 202411:00 amRNSAppointment of Joint-Brokers
5th Feb 20245:15 pmRNSHolding(s) in Company
1st Feb 202412:00 pmRNSTotal Voting Rights
23rd Jan 20244:45 pmRNSDirector/PDMR Shareholding
12th Jan 202410:00 amRNSHolding(s) in Company
11th Jan 20247:05 amRNSFirst Tranche of Share Repurchase Programme
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 202410:15 amRNSTotal Voting Rights
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTransaction in Own Shares
29th Dec 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.